nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—DRD5—bipolar disorder	0.24	0.303	CbGaD
Methotrimeprazine—DRD4—bipolar disorder	0.123	0.155	CbGaD
Methotrimeprazine—DRD3—bipolar disorder	0.106	0.134	CbGaD
Methotrimeprazine—DRD1—bipolar disorder	0.104	0.131	CbGaD
Methotrimeprazine—HTR2C—bipolar disorder	0.0889	0.112	CbGaD
Methotrimeprazine—DRD2—bipolar disorder	0.0733	0.0926	CbGaD
Methotrimeprazine—HTR2A—bipolar disorder	0.0566	0.0715	CbGaD
Methotrimeprazine—DRD3—telencephalic ventricle—bipolar disorder	0.00572	0.108	CbGeAlD
Methotrimeprazine—DRD1—telencephalic ventricle—bipolar disorder	0.00409	0.077	CbGeAlD
Methotrimeprazine—HTR2A—locus ceruleus—bipolar disorder	0.00336	0.0633	CbGeAlD
Methotrimeprazine—HTR2C—telencephalic ventricle—bipolar disorder	0.00318	0.0598	CbGeAlD
Methotrimeprazine—DRD2—telencephalic ventricle—bipolar disorder	0.00242	0.0455	CbGeAlD
Methotrimeprazine—CYP1A2—urine—bipolar disorder	0.00186	0.0351	CbGeAlD
Methotrimeprazine—HTR2A—autonomic nervous system—bipolar disorder	0.00179	0.0336	CbGeAlD
Methotrimeprazine—CYP2E1—urine—bipolar disorder	0.00168	0.0315	CbGeAlD
Methotrimeprazine—HTR2A—telencephalic ventricle—bipolar disorder	0.00159	0.03	CbGeAlD
Methotrimeprazine—HTR2A—urine—bipolar disorder	0.00146	0.0274	CbGeAlD
Methotrimeprazine—CYP2D6—urine—bipolar disorder	0.00133	0.025	CbGeAlD
Methotrimeprazine—CYP1A2—blood plasma—bipolar disorder	0.000972	0.0183	CbGeAlD
Methotrimeprazine—ADRA2A—blood plasma—bipolar disorder	0.000894	0.0168	CbGeAlD
Methotrimeprazine—DRD4—brain—bipolar disorder	0.000881	0.0166	CbGeAlD
Methotrimeprazine—CYP2E1—blood plasma—bipolar disorder	0.000875	0.0165	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—bipolar disorder	0.000872	0.0164	CbGeAlD
Methotrimeprazine—DRD3—nervous system—bipolar disorder	0.00081	0.0152	CbGeAlD
Methotrimeprazine—HTR2A—blood plasma—bipolar disorder	0.00076	0.0143	CbGeAlD
Methotrimeprazine—DRD5—nervous system—bipolar disorder	0.000759	0.0143	CbGeAlD
Methotrimeprazine—CYP2D6—blood plasma—bipolar disorder	0.000693	0.013	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—bipolar disorder	0.000681	0.0128	CbGeAlD
Methotrimeprazine—CHRM4—brain—bipolar disorder	0.000666	0.0125	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—bipolar disorder	0.000622	0.0117	CbGeAlD
Methotrimeprazine—DRD3—brain—bipolar disorder	0.000619	0.0117	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—bipolar disorder	0.000609	0.0115	CbGeAlD
Methotrimeprazine—DRD5—brain—bipolar disorder	0.00058	0.0109	CbGeAlD
Methotrimeprazine—DRD1—nervous system—bipolar disorder	0.00058	0.0109	CbGeAlD
Methotrimeprazine—ADRA2C—adrenal cortex—bipolar disorder	0.000569	0.0107	CbGeAlD
Methotrimeprazine—CHRM5—brain—bipolar disorder	0.000521	0.0098	CbGeAlD
Methotrimeprazine—ADRA1B—brain—bipolar disorder	0.000476	0.00895	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—bipolar disorder	0.000468	0.0088	CbGeAlD
Methotrimeprazine—ADRA1D—brain—bipolar disorder	0.000465	0.00876	CbGeAlD
Methotrimeprazine—CHRM3—thyroid gland—bipolar disorder	0.000453	0.00852	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—bipolar disorder	0.000451	0.00848	CbGeAlD
Methotrimeprazine—DRD1—brain—bipolar disorder	0.000443	0.00835	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—bipolar disorder	0.000426	0.00801	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—bipolar disorder	0.000381	0.00717	CbGeAlD
Methotrimeprazine—CHRM2—brain—bipolar disorder	0.000357	0.00673	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—bipolar disorder	0.00035	0.00658	CbGeAlD
Methotrimeprazine—HTR2C—brain—bipolar disorder	0.000344	0.00648	CbGeAlD
Methotrimeprazine—CYP1A2—thyroid gland—bipolar disorder	0.000344	0.00647	CbGeAlD
Methotrimeprazine—DRD2—nervous system—bipolar disorder	0.000343	0.00645	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—bipolar disorder	0.000333	0.00627	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—bipolar disorder	0.000329	0.00619	CbGeAlD
Methotrimeprazine—CHRM1—brain—bipolar disorder	0.000325	0.00612	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—bipolar disorder	0.000323	0.00607	CbGeAlD
Methotrimeprazine—ADRA2A—thyroid gland—bipolar disorder	0.000316	0.00595	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—bipolar disorder	0.000314	0.0059	CbGeAlD
Methotrimeprazine—CYP2E1—thyroid gland—bipolar disorder	0.000309	0.00582	CbGeAlD
Methotrimeprazine—CHRM3—brain—bipolar disorder	0.000291	0.00548	CbGeAlD
Methotrimeprazine—HRH1—nervous system—bipolar disorder	0.000271	0.00509	CbGeAlD
Methotrimeprazine—ADRA1A—brain—bipolar disorder	0.000267	0.00503	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—bipolar disorder	0.000266	0.005	CbGeAlD
Methotrimeprazine—DRD2—brain—bipolar disorder	0.000262	0.00493	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—bipolar disorder	0.00026	0.0049	CbGeAlD
Methotrimeprazine—ADRA2C—brain—bipolar disorder	0.000255	0.00479	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—bipolar disorder	0.00025	0.00471	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—bipolar disorder	0.000245	0.00461	CbGeAlD
Methotrimeprazine—HTR2A—nervous system—bipolar disorder	0.000226	0.00426	CbGeAlD
Methotrimeprazine—Diltiazem—CACNA1C—bipolar disorder	0.00022	0.0331	CrCbGaD
Methotrimeprazine—HTR2A—cerebellum—bipolar disorder	0.000213	0.004	CbGeAlD
Methotrimeprazine—HRH1—brain—bipolar disorder	0.000207	0.00389	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—bipolar disorder	0.000206	0.00388	CbGeAlD
Methotrimeprazine—ADRA2A—brain—bipolar disorder	0.000203	0.00383	CbGeAlD
Methotrimeprazine—Acetophenazine—DRD1—bipolar disorder	0.000199	0.03	CrCbGaD
Methotrimeprazine—CYP2E1—brain—bipolar disorder	0.000199	0.00374	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—bipolar disorder	0.000194	0.00365	CbGeAlD
Methotrimeprazine—Propericiazine—DRD1—bipolar disorder	0.000176	0.0265	CrCbGaD
Methotrimeprazine—HTR2A—brain—bipolar disorder	0.000173	0.00325	CbGeAlD
Methotrimeprazine—CYP2D6—brain—bipolar disorder	0.000157	0.00296	CbGeAlD
Methotrimeprazine—Cyamemazine—HTR2C—bipolar disorder	0.000151	0.0227	CrCbGaD
Methotrimeprazine—Acetophenazine—DRD2—bipolar disorder	0.000141	0.0212	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD5—bipolar disorder	0.000136	0.0205	CrCbGaD
Methotrimeprazine—Triflupromazine—DRD1—bipolar disorder	0.000122	0.0184	CrCbGaD
Methotrimeprazine—Acepromazine—DRD1—bipolar disorder	0.000113	0.017	CrCbGaD
Methotrimeprazine—Thioproperazine—DRD1—bipolar disorder	0.000111	0.0167	CrCbGaD
Methotrimeprazine—Mesoridazine—DRD3—bipolar disorder	0.000109	0.0165	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD1—bipolar disorder	0.000109	0.0164	CrCbGaD
Methotrimeprazine—Propiomazine—DRD4—bipolar disorder	0.000107	0.0161	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD3—bipolar disorder	0.000106	0.0159	CrCbGaD
Methotrimeprazine—Cyamemazine—HTR2A—bipolar disorder	9.59e-05	0.0144	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD3—bipolar disorder	9.58e-05	0.0144	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD1—bipolar disorder	9.4e-05	0.0142	CrCbGaD
Methotrimeprazine—Acepromazine—HTR1A—bipolar disorder	9.39e-05	0.0141	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2C—bipolar disorder	9.18e-05	0.0138	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR1A—bipolar disorder	9.18e-05	0.0138	CrCbGaD
Methotrimeprazine—Propiomazine—DRD1—bipolar disorder	9.04e-05	0.0136	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR1A—bipolar disorder	9.03e-05	0.0136	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR1A—bipolar disorder	8.91e-05	0.0134	CrCbGaD
Methotrimeprazine—Prochlorperazine—HTR2C—bipolar disorder	8.89e-05	0.0134	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD3—bipolar disorder	8.72e-05	0.0131	CrCbGaD
Methotrimeprazine—Triflupromazine—DRD2—bipolar disorder	8.62e-05	0.013	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD1—bipolar disorder	8.56e-05	0.0129	CrCbGaD
Methotrimeprazine—Thioridazine—DRD1—bipolar disorder	8.1e-05	0.0122	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2C—bipolar disorder	8.04e-05	0.0121	CrCbGaD
Methotrimeprazine—Acepromazine—DRD2—bipolar disorder	7.97e-05	0.012	CrCbGaD
Methotrimeprazine—Promazine—DRD4—bipolar disorder	7.92e-05	0.0119	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR1A—bipolar disorder	7.81e-05	0.0118	CrCbGaD
Methotrimeprazine—Thioproperazine—DRD2—bipolar disorder	7.79e-05	0.0117	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2C—bipolar disorder	7.74e-05	0.0117	CrCbGaD
Methotrimeprazine—Pipotiazine—DRD2—bipolar disorder	7.67e-05	0.0115	CrCbGaD
Methotrimeprazine—Mesoridazine—DRD2—bipolar disorder	7.57e-05	0.0114	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A3—bipolar disorder	7.5e-05	0.0113	CrCbGaD
Methotrimeprazine—Perphenazine—DRD1—bipolar disorder	7.43e-05	0.0112	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2C—bipolar disorder	7.35e-05	0.0111	CrCbGaD
Methotrimeprazine—Prochlorperazine—DRD2—bipolar disorder	7.33e-05	0.011	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2C—bipolar disorder	7.32e-05	0.011	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD4—bipolar disorder	6.97e-05	0.0105	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2C—bipolar disorder	6.93e-05	0.0104	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2C—bipolar disorder	6.77e-05	0.0102	CrCbGaD
Methotrimeprazine—Thioridazine—HTR1A—bipolar disorder	6.73e-05	0.0101	CrCbGaD
Methotrimeprazine—Promazine—DRD1—bipolar disorder	6.7e-05	0.0101	CrCbGaD
Methotrimeprazine—Fluphenazine—DRD2—bipolar disorder	6.63e-05	0.00998	CrCbGaD
Methotrimeprazine—Trimipramine—HTR1A—bipolar disorder	6.57e-05	0.00989	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2C—bipolar disorder	6.43e-05	0.00968	CrCbGaD
Methotrimeprazine—Propiomazine—DRD2—bipolar disorder	6.37e-05	0.0096	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2C—bipolar disorder	6.36e-05	0.00958	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR1A—bipolar disorder	6.24e-05	0.0094	CrCbGaD
Methotrimeprazine—Perphenazine—HTR1A—bipolar disorder	6.17e-05	0.0093	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—bipolar disorder	6.16e-05	0.00928	CrCbGaD
Methotrimeprazine—Clomipramine—SLC6A4—bipolar disorder	6.09e-05	0.00918	CrCbGaD
Methotrimeprazine—Chlorprothixene—DRD2—bipolar disorder	6.03e-05	0.00909	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—bipolar disorder	6.02e-05	0.00907	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD3—bipolar disorder	6.01e-05	0.00905	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—bipolar disorder	5.92e-05	0.00892	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD1—bipolar disorder	5.9e-05	0.00888	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—bipolar disorder	5.85e-05	0.00881	CrCbGaD
Methotrimeprazine—Promazine—HTR2C—bipolar disorder	5.73e-05	0.00863	CrCbGaD
Methotrimeprazine—Thioridazine—DRD2—bipolar disorder	5.71e-05	0.0086	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A4—bipolar disorder	5.61e-05	0.00845	CrCbGaD
Methotrimeprazine—Trimipramine—DRD2—bipolar disorder	5.58e-05	0.0084	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A3—bipolar disorder	5.56e-05	0.00838	CrCbGaD
Methotrimeprazine—Promethazine—DRD2—bipolar disorder	5.37e-05	0.00809	CrCbGaD
Methotrimeprazine—Trifluoperazine—DRD2—bipolar disorder	5.3e-05	0.00798	CrCbGaD
Methotrimeprazine—Perphenazine—DRD2—bipolar disorder	5.24e-05	0.00789	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—bipolar disorder	5.12e-05	0.00771	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2C—bipolar disorder	5.04e-05	0.0076	CrCbGaD
Methotrimeprazine—Imipramine—HTR2C—bipolar disorder	5.02e-05	0.00756	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—bipolar disorder	4.93e-05	0.00742	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR1A—bipolar disorder	4.9e-05	0.00738	CrCbGaD
Methotrimeprazine—Imipramine—HTR1A—bipolar disorder	4.87e-05	0.00734	CrCbGaD
Methotrimeprazine—Promazine—DRD2—bipolar disorder	4.72e-05	0.00712	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—bipolar disorder	4.68e-05	0.00705	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—bipolar disorder	4.66e-05	0.00702	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—bipolar disorder	4.41e-05	0.00665	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—bipolar disorder	4.31e-05	0.00649	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A4—bipolar disorder	4.16e-05	0.00626	CrCbGaD
Methotrimeprazine—Chlorpromazine—DRD2—bipolar disorder	4.16e-05	0.00626	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—bipolar disorder	4.15e-05	0.00625	CrCbGaD
Methotrimeprazine—Imipramine—DRD2—bipolar disorder	4.14e-05	0.00623	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—bipolar disorder	4.09e-05	0.00617	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—bipolar disorder	4.05e-05	0.0061	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—bipolar disorder	3.65e-05	0.0055	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—bipolar disorder	3.21e-05	0.00484	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—bipolar disorder	3.2e-05	0.00481	CrCbGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ADCY2—bipolar disorder	6.39e-06	4.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NTRK2—bipolar disorder	6.37e-06	4.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TCF7L2—bipolar disorder	6.36e-06	4.29e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—INS—bipolar disorder	6.36e-06	4.28e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—DRD3—bipolar disorder	6.34e-06	4.27e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD1—bipolar disorder	6.32e-06	4.26e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HTR2C—bipolar disorder	6.32e-06	4.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—DRD2—bipolar disorder	6.32e-06	4.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GSK3A—bipolar disorder	6.31e-06	4.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	6.31e-06	4.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	6.31e-06	4.25e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	6.28e-06	4.23e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	6.27e-06	4.22e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	6.26e-06	4.22e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	6.25e-06	4.21e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD3—bipolar disorder	6.24e-06	4.2e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	6.23e-06	4.2e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD3—bipolar disorder	6.23e-06	4.19e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	6.22e-06	4.19e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NTRK2—bipolar disorder	6.21e-06	4.18e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	6.21e-06	4.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	6.21e-06	4.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—ADCY2—bipolar disorder	6.2e-06	4.18e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	6.2e-06	4.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—NRG1—bipolar disorder	6.19e-06	4.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD3—bipolar disorder	6.19e-06	4.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	6.18e-06	4.16e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GSK3A—bipolar disorder	6.16e-06	4.15e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—DRD4—bipolar disorder	6.16e-06	4.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NTRK2—bipolar disorder	6.15e-06	4.14e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—POMC—bipolar disorder	6.15e-06	4.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	6.14e-06	4.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD3—bipolar disorder	6.13e-06	4.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NTRK1—bipolar disorder	6.13e-06	4.13e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	6.11e-06	4.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GSK3A—bipolar disorder	6.1e-06	4.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	6.09e-06	4.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	6.08e-06	4.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	6.07e-06	4.09e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD4—bipolar disorder	6.06e-06	4.08e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD4—bipolar disorder	6.04e-06	4.07e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	6.02e-06	4.06e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD4—bipolar disorder	6e-06	4.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—POMC—bipolar disorder	5.98e-06	4.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	5.98e-06	4.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	5.98e-06	4.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—S100B—bipolar disorder	5.95e-06	4.01e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD4—bipolar disorder	5.95e-06	4.01e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	5.93e-06	3.99e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—HTR2A—bipolar disorder	5.91e-06	3.98e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—NRG1—bipolar disorder	5.9e-06	3.97e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	5.89e-06	3.97e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	5.88e-06	3.96e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	5.88e-06	3.96e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	5.87e-06	3.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CLOCK—bipolar disorder	5.86e-06	3.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	5.86e-06	3.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	5.86e-06	3.95e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	5.85e-06	3.94e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—POMC—bipolar disorder	5.83e-06	3.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—HTR2A—bipolar disorder	5.83e-06	3.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—NRG1—bipolar disorder	5.82e-06	3.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—NRG1—bipolar disorder	5.82e-06	3.92e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	5.79e-06	3.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—COMT—bipolar disorder	5.79e-06	3.9e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—POMC—bipolar disorder	5.78e-06	3.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	5.77e-06	3.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	5.76e-06	3.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—MAOA—bipolar disorder	5.75e-06	3.87e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NTRK1—bipolar disorder	5.72e-06	3.85e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—S100B—bipolar disorder	5.72e-06	3.85e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—TSHB—bipolar disorder	5.71e-06	3.85e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CACNB2—bipolar disorder	5.71e-06	3.85e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—TPH2—bipolar disorder	5.71e-06	3.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	5.7e-06	3.84e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	5.7e-06	3.84e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—ADCY2—bipolar disorder	5.7e-06	3.84e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	5.69e-06	3.83e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	5.68e-06	3.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	5.68e-06	3.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	5.67e-06	3.82e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	5.67e-06	3.82e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ADCY2—bipolar disorder	5.65e-06	3.81e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	5.65e-06	3.81e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	5.65e-06	3.81e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—DRD2—bipolar disorder	5.64e-06	3.8e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TCF7L2—bipolar disorder	5.63e-06	3.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	5.63e-06	3.79e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—DRD2—bipolar disorder	5.63e-06	3.79e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—DPYD—bipolar disorder	5.62e-06	3.79e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	5.61e-06	3.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ADCY2—bipolar disorder	5.6e-06	3.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—DRD2—bipolar disorder	5.59e-06	3.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—HTR2A—bipolar disorder	5.58e-06	3.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	5.58e-06	3.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TCF7L2—bipolar disorder	5.58e-06	3.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	5.56e-06	3.75e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—S100B—bipolar disorder	5.56e-06	3.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—DRD2—bipolar disorder	5.54e-06	3.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	5.52e-06	3.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	5.51e-06	3.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	5.47e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—POMC—bipolar disorder	5.43e-06	3.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	5.35e-06	3.61e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—POMC—bipolar disorder	5.34e-06	3.6e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—POMC—bipolar disorder	5.33e-06	3.59e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	5.32e-06	3.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	5.31e-06	3.58e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—COMT—bipolar disorder	5.31e-06	3.58e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—POMC—bipolar disorder	5.3e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—MTHFR—bipolar disorder	5.29e-06	3.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MAOA—bipolar disorder	5.27e-06	3.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—NRG1—bipolar disorder	5.26e-06	3.54e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—HTR2A—bipolar disorder	5.25e-06	3.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—HTR2A—bipolar disorder	5.25e-06	3.54e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—POMC—bipolar disorder	5.25e-06	3.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	5.23e-06	3.52e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	5.22e-06	3.52e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	5.19e-06	3.5e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	5.19e-06	3.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	5.17e-06	3.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	5.13e-06	3.46e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	5.11e-06	3.44e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	5.1e-06	3.43e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	5.09e-06	3.43e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	5.08e-06	3.42e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NTRK1—bipolar disorder	5.06e-06	3.41e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—NRG1—bipolar disorder	5.05e-06	3.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—S100B—bipolar disorder	5.05e-06	3.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NTRK1—bipolar disorder	5.02e-06	3.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	5e-06	3.37e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CLOCK—bipolar disorder	4.97e-06	3.35e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—S100B—bipolar disorder	4.97e-06	3.34e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—S100B—bipolar disorder	4.95e-06	3.34e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—S100B—bipolar disorder	4.94e-06	3.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—S100B—bipolar disorder	4.92e-06	3.32e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NRG1—bipolar disorder	4.91e-06	3.31e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—COMT—bipolar disorder	4.88e-06	3.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—S100B—bipolar disorder	4.88e-06	3.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	4.86e-06	3.28e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	4.86e-06	3.27e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MAOA—bipolar disorder	4.84e-06	3.26e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CACNB2—bipolar disorder	4.84e-06	3.26e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—TSHB—bipolar disorder	4.84e-06	3.26e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—TPH2—bipolar disorder	4.84e-06	3.26e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	4.83e-06	3.25e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—DPYD—bipolar disorder	4.76e-06	3.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—GSK3B—bipolar disorder	4.76e-06	3.2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—HTR2A—bipolar disorder	4.74e-06	3.19e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—POMC—bipolar disorder	4.72e-06	3.18e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—GSK3B—bipolar disorder	4.69e-06	3.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—INS—bipolar disorder	4.69e-06	3.16e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—MTHFR—bipolar disorder	4.68e-06	3.15e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—POMC—bipolar disorder	4.66e-06	3.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	4.65e-06	3.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—INS—bipolar disorder	4.63e-06	3.12e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—SNAP25—bipolar disorder	4.57e-06	3.08e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	4.55e-06	3.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	4.52e-06	3.04e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—GSK3B—bipolar disorder	4.49e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—POMC—bipolar disorder	4.46e-06	3e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NRG1—bipolar disorder	4.45e-06	3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—INS—bipolar disorder	4.43e-06	2.99e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	4.43e-06	2.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—HTR2A—bipolar disorder	4.43e-06	2.98e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NRG1—bipolar disorder	4.38e-06	2.95e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NRG1—bipolar disorder	4.37e-06	2.95e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	4.36e-06	2.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	4.36e-06	2.93e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NRG1—bipolar disorder	4.35e-06	2.93e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	4.31e-06	2.91e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NRG1—bipolar disorder	4.3e-06	2.9e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—MTHFR—bipolar disorder	4.29e-06	2.89e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	4.29e-06	2.89e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	4.28e-06	2.88e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.26e-06	2.87e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—POMC—bipolar disorder	4.25e-06	2.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—POMC—bipolar disorder	4.23e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—GSK3B—bipolar disorder	4.23e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—GSK3B—bipolar disorder	4.23e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—INS—bipolar disorder	4.22e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—INS—bipolar disorder	4.2e-06	2.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—POMC—bipolar disorder	4.19e-06	2.82e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—POMC—bipolar disorder	4.19e-06	2.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—INS—bipolar disorder	4.17e-06	2.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—INS—bipolar disorder	4.17e-06	2.81e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—ADCY2—bipolar disorder	4.04e-06	2.72e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	4.02e-06	2.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	3.99e-06	2.69e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	3.94e-06	2.66e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—MTHFR—bipolar disorder	3.94e-06	2.66e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	3.93e-06	2.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—HTR2A—bipolar disorder	3.92e-06	2.64e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—HTR2A—bipolar disorder	3.88e-06	2.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	3.87e-06	2.61e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—SNAP25—bipolar disorder	3.87e-06	2.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—GSK3B—bipolar disorder	3.81e-06	2.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—POMC—bipolar disorder	3.78e-06	2.55e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—INS—bipolar disorder	3.76e-06	2.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—POMC—bipolar disorder	3.74e-06	2.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—INS—bipolar disorder	3.72e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	3.66e-06	2.47e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—POMC—bipolar disorder	3.63e-06	2.45e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—INS—bipolar disorder	3.61e-06	2.43e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	3.6e-06	2.42e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—GSK3B—bipolar disorder	3.56e-06	2.4e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—POMC—bipolar disorder	3.53e-06	2.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—INS—bipolar disorder	3.52e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	3.51e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	3.48e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—COMT—bipolar disorder	3.46e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—INS—bipolar disorder	3.46e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MAOA—bipolar disorder	3.44e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—POMC—bipolar disorder	3.43e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—ADCY2—bipolar disorder	3.42e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—INS—bipolar disorder	3.41e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	3.23e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—POMC—bipolar disorder	3.21e-06	2.16e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—INS—bipolar disorder	3.19e-06	2.15e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	3.18e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	3.17e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	3.16e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—POMC—bipolar disorder	3.16e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GSK3B—bipolar disorder	3.15e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—POMC—bipolar disorder	3.15e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—POMC—bipolar disorder	3.15e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—POMC—bipolar disorder	3.14e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—INS—bipolar disorder	3.14e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—INS—bipolar disorder	3.14e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—INS—bipolar disorder	3.13e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—POMC—bipolar disorder	3.13e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GSK3B—bipolar disorder	3.12e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—INS—bipolar disorder	3.12e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	3.12e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—INS—bipolar disorder	3.11e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—POMC—bipolar disorder	3.1e-06	2.09e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	3.09e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—INS—bipolar disorder	3.08e-06	2.08e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—INS—bipolar disorder	3.07e-06	2.07e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—COMT—bipolar disorder	2.93e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MAOA—bipolar disorder	2.91e-06	1.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	2.89e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	2.87e-06	1.93e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—INS—bipolar disorder	2.86e-06	1.92e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.8e-06	1.88e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—bipolar disorder	2.37e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—POMC—bipolar disorder	2.24e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—INS—bipolar disorder	2.23e-06	1.5e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—POMC—bipolar disorder	1.9e-06	1.28e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—INS—bipolar disorder	1.88e-06	1.27e-05	CbGpPWpGaD
